Marker Therapeutics, Inc. — Director's Dealing 2004

Feb 17, 2004

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: GENEMAX CORP (GMXX)
CIK: 0001094038
Period of Report: 2003-12-31

Reporting Person: JEFFERIES WILFRED (Director, Chief Scientist Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2003-12-31	Common Stock $0.001 par value	A	0	$0.00	Acquired	0	Direct
2003-12-31	Common Stock $0.001 par value	A	0	—	Disposed	2770465	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-12-16	Stock Options	$0.50	A	1500000	Acquired	2011-12-16	Common Stock (1500000)	Direct
2003-12-31	Stock Options	$1.00	A	0	Acquired	2005-10-01	Common Stock (0.00)	Direct

Footnotes

F1: Held of record by 442668 B.C. Ltd., pursuant to which Dr. Jefferies has sole voting and disposition rights.

F2: Granted in accordance with the terms and provisions of the Stock Option Plan dated December 16, 2003, in consideration of services and duties performed.